1. Home
  2. NBY vs TXMD Comparison

NBY vs TXMD Comparison

Compare NBY & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$1.37

Market Cap

31.6M

Sector

N/A

ML Signal

HOLD

Logo TherapeuticsMD Inc.

TXMD

TherapeuticsMD Inc.

HOLD

Current Price

$2.30

Market Cap

25.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBY
TXMD
Founded
2000
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.6M
25.9M
IPO Year
2007
2012

Fundamental Metrics

Financial Performance
Metric
NBY
TXMD
Price
$1.37
$2.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
605.1K
20.1K
Earning Date
03-31-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
35.42
80.61
EPS
0.76
N/A
Revenue
$370,000.00
$1,761,000.00
Revenue This Year
$23.91
$427.09
Revenue Next Year
$32.05
N/A
P/E Ratio
$1.57
$90.64
Revenue Growth
N/A
35.25
52 Week Low
$0.43
$0.84
52 Week High
$19.95
$2.95

Technical Indicators

Market Signals
Indicator
NBY
TXMD
Relative Strength Index (RSI) 46.00 58.03
Support Level $0.99 $2.10
Resistance Level $1.85 $2.35
Average True Range (ATR) 0.19 0.11
MACD 0.11 0.00
Stochastic Oscillator 36.49 96.43

Price Performance

Historical Comparison
NBY
TXMD

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

Share on Social Networks: